Press Release

According to Research for Markets, the Global Blood Screening market is expected to grow from $1.84 billion in 2016 to reach $3.97 billion by 2023 with a CAGR of 11.6%. Growing incidence of infectious diseases, rise in consciousness of donating blood, and increase in health care awareness are some of the factors boosting the market growth. In addition, technological advancements in blood screening techniques, increasing investments in research & development are some of the other factors fuelling the market growth during the forecast period. However, threat from substitute techniques, initial investment costs are some of the restraints limiting the market growth.

Get a Sample copy of this report: https://www.researchformarkets.com/sample/blood-screening-global-market-5013

Blood Screening tests are the foundation of a successful health care system, providing critical information that health care provider and patients need to make the right medical decisions. Blood screening often provide objective, quantitative measurements that inform every stage of care—prevention, detection, diagnosis, treatment, and successful management of health conditions.

Blood Screening
North America accounted for the largest share in global blood screening market followed by Europe. Growth of the region is attributed to existence of major companies and developed healthcare infrastructure. Asia Pacific is expected to witness huge growth due to developing economies, raising health care expenditure, and increasing demand for blood screening in emerging countries such as China, Japan and India.

Some of the key players in global blood screening market include Abbott Laboratories, Alere Inc., Apex Biotechnology Corp., Beckman Coulter (A Subsidiary of Danaher Corporation), Becton, Dickinson and Company, Biomérieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche, Grifols, Hemosense Inc., Luminex Corp., Nova Biomedical Corp., Ortho Clinical Diagnostics, Inc., Roche Diagnostics, Siemens Healthineers (A Subsidiary of Siemens AG), Thermo Fisher Scientific, Inc., and Trinity Biotech.

Technologies Covered:
• Next-generation Sequencing (NGS)
• Rapid Tests
• Western Blot Assay
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Nucleic Acid Test (NAT)

Product & Service Types Covered:
• Software and Services
• Instruments
• Reagents & Kits

Applications Covered:
• Diabetes Blood Testing
• Cardiovascular Disease Blood Testing
• Cancer Blood Testing
• Blood Disorder Blood Testing
• Autoimmune Disease And Food Allergy Testing
• Pregnancy Blood Testing
• Liver Disorder Blood Testing
• Kidney Disorder Blood Testing
• Home-Monitoring Blood Testing
• Fertility Blood Testing

End Users Covered:
• Blood Banks
• Hospitals

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

Get Discount on Report: https://www.researchformarkets.com/discount/blood-screening-global-market-5013

About us:

Research for Markets indulge in detailed and diligent research on different markets, trends and emerging opportunities in the successive direction to cater to your business needs. We have established the pillars of our flourishing institute on the grounds of Credibility and Reliability. RFM delve into the markets across Asia Pacific, North America, South America, Europe, Middle East and Africa.

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Contact Info:

Name: Research For Markets

Email: [email protected]

Phone: +44 8000-4182-37

www.researchformarkets.com